Bradford Crutchfield
Director/Board Member bei Partillion Bioscience Corp.
Profil
Bradford J.
Crutchfield currently works at Partillion Bioscience Corp., as Director from 2023.
Mr. Crutchfield also formerly worked at NanoString Technologies, Inc., as Independent Director from 2013 to 2014, Bio-Rad Laboratories, Inc., as EVP & President-Life Sciences Group from 2012 to 2014, Illumina, Inc., as Vice President & General Manager-EMEA from 2014 to 2015, Life Science Group, Inc., as President & Executive Vice President from 2013 to 2014, 10X Genomics, Inc., as Chief Commercial Officer from 2017 to 2022, and QIAGEN GmbH, as Senior Vice President-Life Sciences Business Area from 2015 to 2017.
Mr. Crutchfield received his undergraduate degree from the University of California, Davis.
Aktive Positionen von Bradford Crutchfield
| Unternehmen | Position | Beginn |
|---|---|---|
Partillion Bioscience Corp.
 Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Director/Board Member | 26.09.2023 |
Ehemalige bekannte Positionen von Bradford Crutchfield
| Unternehmen | Position | Ende |
|---|---|---|
| 10X GENOMICS, INC. | Corporate Officer/Principal | 27.07.2022 |
QIAGEN GmbH
 QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Corporate Officer/Principal | 01.02.2017 |
| ILLUMINA, INC. | Corporate Officer/Principal | 01.04.2015 |
| NANOSTRING TECHNOLOGIES, INC. | Director/Board Member | 29.10.2014 |
| Life Science Group, Inc. | President | 26.08.2014 |
Ausbildung von Bradford Crutchfield
| University of California, Davis | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIO-RAD LABORATORIES, INC. | Health Technology |
| ILLUMINA, INC. | Health Technology |
| 10X GENOMICS, INC. | Health Technology |
| NANOSTRING TECHNOLOGIES, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Life Science Group, Inc. | Health Technology |
QIAGEN GmbH
QIAGEN GmbH Miscellaneous Commercial ServicesCommercial Services QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany. | Commercial Services |
Partillion Bioscience Corp.
Partillion Bioscience Corp. Miscellaneous Commercial ServicesCommercial Services Partillion Bioscience Corp. is an American company that specializes in providing a functional single-cell biology reagent platform. The company's nanovial technology allows for single-cell secretion analysis and other research capabilities. The company was founded by Joseph Michael de Rutte and Dino Di Carlo, with Joseph Michael de Rutte serving as CEO since incorporation. | Commercial Services |
